인성크로마텍 로고

검색버튼
퀵메뉴 펼침

o
p
e
n
c
l
o
s
e

AlbuVoid™ LC-MS On-Bead
제품명: AlbuVoid™ LC-MS On-Bead
용도: Albumin Depletion with On-Bead Digestion for Proteomics
메이커: Biotech Support Group
카달로그:


소개

 

AlbuVoid™ LC-MS On-Bead      Albumin Depletion with On-Bead Digestion for Proteomics

 

Albumin Depletion Plus Low Abundance Serum Protein 

Enrichment AlbuVoid™ LC-MS On-Bead.PNGWith Optimized On-Bead Digestion for 

LC-MS Label and Label-free Analyses


•  Albumin and transferrin voids in flow-through >95%, with <30 minute 

   bind/wash microfuge protocol

•  Low abundance enrichment equivalent or better than hexa-peptides 

   or immuno-affinity

•  Consumable, cost-effective, no column regeneration or cross-contamination

•  Species agnostic; human, rat, mouse, goat, sheep, porcine and bovine sera 

   have been tested

•  Trypsin digestion on the bead

•  Seamless workflows and unique proteolytic efficiencies

  -  No in-gel digests, no solution digests, no C18 desalting, more consistent, 

     reproducible results

  -  Compatibility with quantitative label (i.e., iTRAQ) and label-free LC-MS 

     methods

 

AlbuVoid™ LC-MS On-Bead is an albumin depletion reagent kit. It removes albumin from serum and plasma samples while concentrating low abundance proteins on the beads. Consequently, the low abundance serum proteins are enriched. It is ideal for applications involving LC-MS discovery and targeted proteomics.


The AlbuVoid™ beads are derived from a silica-based library of individual mixed-mode polymeric ligands. The library was designed to facilitate weak binding of proteins, allowing for progressive enrichment of the low abundance proteome, with specialized voiding properties empirically derived.

 

The total AlbuVoid™ LC-MS On-Bead proteins were compared for human and rat sera at two different digestion times, 4 hours and overnight (O/N). Note that many identified proteins overlap while certain populations of proteins were only observed in one or the other digest time. Download the detailed report


The AlbuVoid™ LC-MS On-Bead product and protocol is compatible with both label and label-free quantification of peptides/proteins. In the example below, iTRAQ labeled peptides from two representative proteins observed to be differentially quantified in comparing pooled sera from normal and cancer patients.

 

 

☞   Click Here For The AlbuVoid™ LC-MS On-Bead For Serum Proteomics Product Sheet

 


참고자료 :     

•   AlbuVoid™ for Studying the Albumin Fraction for Drug and Protein Interactions & Analyzing the Unbound Fraction forAlbuminome 

    Subproteome Biomarker Discovery from Biotech Support Group 

•   6 Reasons To Choose AlbuVoid™ For Novel Serum Biomarkers In Umbilical Cord Serum Proteomics And Stem CellTreatments from 

    Biotech Support Group

 


AlbuVoid™ LC-MS On-Bead 프로토콜 : 

 

AlbuVoid™ LC-MS On-Bead_프로토콜.PNG


주문정보

주문정보.PNG


주문정보_2.PNG

관련자료

References

Serum 

Haiyan Zheng, Caifeng Zhao, Meiqian Qian, Swapan Roy, Absari Arpa, Amenah Soherwardy and Matthew Kuruc. AlbuVoid™ Coupled to On-Bead Digestion - Tackling the Challenges of Serum ProteomicsJ Proteomics Bioinform 2015, 8:9. 

Grubbs, J. K., et al. " Investigation of the efficacy of albumin removal procedures on porcine serum proteome profile1." (2015). 

Discovery of Functional Serum Biomarkers Using AlbuVoid™ Enrichment and the ArrayBridge PEP Profiling Platform.Personal communication, Xing Wang, Ph.D., ArrayBridge (St. Louis, MO), manuscripts in process. 

Serum Profiling Making Mark on Predictive Medicine Vicki Glaser.Genetic Engineering & Biotechnology News. 2011;31(7):1-55. 

Kuruc Matt, Dr.Roy. Application Report - AlbuVoid™ LC-MS On-Bead – Differential Expression of Cancer Sera Proteins Using Quantitative (iTRAQ) Proteomics


Plasma

Espes, Daniel, Joey Lau, and Per-Ola Carlsson. "Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes." Diabetologia(2013): 1-4. 

Patent - Secretome Sample Preparation

Narain, Niven Rajin, and Paula Patricia Narain. "COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER." U.S. Patent No. 20,150,023,949. 22 Jan. 2015.

Narain, Niven Rajin, Rangaprasad Sarangarajan, and Vivek K. Vishnudas. " INTERROGATORY CELL-BASED ASSAYS AND USES THEREOF." U.S. Patent No. 20,120,258,874. 11 Oct. 2012.


Cell Culture

Narain, Niven Rajin, Rangaprasad Sarangarajan, Vivek K. Vishnudas, and Michael Andrew Kiebish. "USE OF MARKERS IN THE IDENTIFICATION OF CARDIOTOXIC AGENTS AND IN THE DIAGNOSIS AND MONITORING OF CARDIOMYOPATHY AND CARDIOVASCULAR DISEASE." U.S. Patent 20,140,100,128, issued April 10, 2014. 


On-Bead Digestion Protocols For LC-MS Proteomic Workflows

New on-bead digestion for LC-MS applications for proteomic studies


US HUPO 2014. Frontiers in Proteomics: Advancing Biology through Technology and Computation.

AlbuVoid™ abstract entitled "Improved proteomic enrichment and workflow strategies", poster board 089 presented at US HUPO 2014